Bal Pharma Ltd - ESG Rating & Company Profile powered by AI
The page is a free E,S&G assessment for Bal Pharma Ltd. The Disclosure score includes seventeen UN SDGs including: 'Good Health & Wellbeing', 'Climate Action' and 'Life below Water'. The assessment of Bal Pharma Ltd is prepared by All Street Sevva using cutting edge NLP.
Bal Pharma Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.4; made up of an environmental score of 0.0, social score of 5.3 and governance score of 8.0.
4.4
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
868 | Trevena Inc | 4.5 | High |
868 | Urogen Pharma Ltd | 4.5 | High |
910 | Bal Pharma Ltd | 4.4 | High |
910 | CanBas Co Ltd | 4.4 | High |
910 | CNS Pharmaceuticals Inc | 4.4 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Bal Pharma Ltd have an accelerator or VC vehicle to help deliver innovation?
Does Bal Pharma Ltd disclose current and historical energy intensity?
Does Bal Pharma Ltd report the average age of the workforce?
Does Bal Pharma Ltd reference operational or capital allocation in relation to climate change?
Does Bal Pharma Ltd disclose its ethnicity pay gap?
Does Bal Pharma Ltd disclose cybersecurity risks?
Does Bal Pharma Ltd offer flexible work?
Does Bal Pharma Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Bal Pharma Ltd disclose the number of employees in R&D functions?
Does Bal Pharma Ltd conduct supply chain audits?
Does Bal Pharma Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Bal Pharma Ltd conduct 360 degree staff reviews?
Does Bal Pharma Ltd disclose the individual responsible for D&I?
Does Bal Pharma Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Bal Pharma Ltd disclose current and / or historical scope 2 emissions?
Does Bal Pharma Ltd disclose water use targets?
Does Bal Pharma Ltd have careers partnerships with academic institutions?
Did Bal Pharma Ltd have a product recall in the last two years?
Does Bal Pharma Ltd disclose incidents of discrimination?
Does Bal Pharma Ltd allow for Work Councils/Collective Agreements to be formed?
Has Bal Pharma Ltd issued a profit warning in the past 24 months?
Does Bal Pharma Ltd disclose parental leave metrics?
Does Bal Pharma Ltd disclose climate scenario or pathway analysis?
Does Bal Pharma Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Bal Pharma Ltd disclose the pay ratio of women to men?
Does Bal Pharma Ltd support suppliers with sustainability related research and development?
Does Bal Pharma Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Bal Pharma Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Bal Pharma Ltd involved in embryonic stem cell research?
Does Bal Pharma Ltd disclose GHG and Air Emissions intensity?
Does Bal Pharma Ltd disclose its waste policy?
Does Bal Pharma Ltd report according to TCFD requirements?
Does Bal Pharma Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Bal Pharma Ltd disclose energy use targets?
Does Bal Pharma Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Bal Pharma Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for Bal Pharma Ltd
These potential risks are based on the size, segment and geographies of the company.
Bal Pharma Limited manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers prescription drugs, generics, OTC products, intravenous infusion products, and bulk actives. It provides anti-infectives, pain management, respiratory care, and women's health products under the Aziwin, Ebay, Balvibe, MNF, Ocium, and Monogesic Plus Gel brands; diabetic care products under the Diabend and Diabend M Group brands; herbal/ayurvedic preparations targeting conditions, such as prostrate enlargement, renal calculi, male infertility, women health, etc. under the Stonex, Ashwamed, Prostowin, Suswas, Menoleap, and Ayursulin brands; anti-hypertensive, anti-lipidemic, and anti-obese products; skin care and bone health products; and cardiac care products under the Secremet and Servace brands. In addition, the company offers a range of APIs for therapeutic areas, such as anti-histamine, platelet inhibitor, anti-diabetic, anti convulsant, urinary incontinence, neuropathic pain, anti-allergy, anti-inflammatory, diuretic, acne treatment, etc.; and various formulations. Further, it engages in the treatment of gastrointestinal disorders; and piles, fistula, and constipation. Bal Pharma Limited was incorporated in 1987 and is based in Bengaluru, India.